Evidence map›Paper›PMID 37047119›Full record

ArticleInternational journal of molecular sciences2023

In Vitro Studies of Nanoparticles as a Potentially New Antimicrobial Agent for the Prevention and Treatment of Lameness and Digital Dermatitis in Cattle.

Magdalena Kot, Aleksandra Kalińska, Sławomir Jaworski, Mateusz Wierzbicki, Sebastian Smulski, Marcin Gołębiewski

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.7field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Magdalena KotAnimal Breeding Department, Warsaw University of Life Sciences, 02-786 Warszawa, Poland.ORCID 0000-0002-2002-163X
Aleksandra KalińskaAnimal Breeding Department, Warsaw University of Life Sciences, 02-786 Warszawa, Poland.ORCID 0000-0001-5861-0635
Sławomir JaworskiDepartment of Nanobiotechnology, Warsaw University of Life Sciences, 02-786 Warszawa, Poland.
Mateusz WierzbickiDepartment of Nanobiotechnology, Warsaw University of Life Sciences, 02-786 Warszawa, Poland.ORCID 0000-0003-3623-8929
Sebastian SmulskiDepartment of Internal Diseases and Diagnostics, Poznań University of Life Sciences, 60-637 Poznań, Poland.ORCID 0000-0001-6405-8226
Marcin GołębiewskiAnimal Breeding Department, Warsaw University of Life Sciences, 02-786 Warszawa, Poland.ORCID 0000-0003-0645-433X
Warsaw University of Life Sciences · PLUniversity of Life Sciences in Poznań · PL

Funding

National Centre for Research and Development LIDER/6/0070/L-7/15/NCBR/2016
6 · The paper itself

Abstract

Digital dermatitis (DD) is the second most prevalent disease in dairy cattle. It causes significant losses for dairy breeders and negatively impacts cows' welfare and milk yield. Despite this, its etiology has not been entirely identified, and available data are limited. Antibiotic therapy is a practical method for managing animal health, but overuse has caused the evolution of antibiotic-resistant bacteria, leading to a loss in antimicrobial efficacy. The antimicrobial properties of metal nanoparticles (NPs) may be a potential alternative to antibiotics. The aim of this study was to determine the biocidal properties of AgNPs, CuNPs, AuNPs, PtNPs, FeNPs, and their nanocomposites against pathogens isolated from cows suffering from hoof diseases, especially DD. The isolated pathogens included

Indexed as

Anti-Infective AgentsCattle DiseasesDigital DermatitisMetal NanoparticlesAnimalsAnti-Bacterial AgentsCattleDairyingFemaleGoldLameness, AnimalOchrobactrumAnti-Bacterial AgentsAnti-Infective AgentsGoldcopperdairy cowsdigital dermatitisgoldironlamenessnanocompositesnanoparticlesplatinumsilver

Identifiers

PMID37047119
PMCPMC10094334
OpenAlexW4360862300

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.